subscribe
 

MRI technology for Japanese market

26th May 2015


Biotronik, a leading manufacturer of cardiovascular medical technology that offers a large portfolio of Magnetic Resonance Imaging (MRI) compatible cardiac implants, has announced the Japanese market release of its ProMRI Iforia 7 DR-T and VR-T DF4 implantable cardiac defibrillators (ICDs). The dual- and single-chamber Iforia 7 ICDs offer patients full-body MRI scans at standard 1.5 tesla scan strength.

The Iforia 7 ICDs use the now common three-in-one DF4 lead connector system. The single-chamber Iforia 7 is one of the smallest cardiac implants on the market, yet it still features Biotronik Home Monitoring technology, which transmits patient medical data and device status on a daily basis, enabling the respective physician to adapt therapy solutions at a very early stage. In addition, the DF4 technology simplifies the implantation procedure. The small size of the device makes it more comfortable for the patient and leads to a better cosmetic result.

“Although MR conditional ICDs have already been approved, some previous models came with limitations in terms of testing conditions as well as the area allowed for MRI scanning,” commented Dr. Koichi Inoue, Cardiovascular Center, Sakurabashi Watanabe Hospital, Osaka, Japan. He added: “The new Iforia 7 ICDs have no limitation for the scanning area, and a range of Biotronik MR conditional cardiovascular implantable electronic devices are now offered, which have fewer testing conditions than before. This is a welcome progression for both patients and physicians.”





Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe